SARS-CoV-2 variants: A double-edged sword?
- PMID: 34024159
- PMCID: PMC8719041
- DOI: 10.1177/15353702211014146
SARS-CoV-2 variants: A double-edged sword?
Abstract
Since the worldwide emergence of the COVID-19 outbreak, there have been international concerns about the possible viral evolution into variants with underlying mutations that may contribute to their increased transmissibility, disease severity, risk of death, and their potential escape from the immune response or may even lead to its extinction. Rigorous surveillance has revealed the variants harboring mutations in the spike protein, the main target of neutralizing antibodies generated through vaccination or herd immunity. In this review, we have highlighted major SARS-CoV-2 variants as well as other local strains along with their specific mutations, suspected changes in their characteristics, and their impact on the current pandemic and vaccine efficacy. We have also emphasized the need to develop widely protective interventions to curb further transmission of variants.
Keywords: B.1.1.7; COVID-19; SARS-CoV-2; mutations; spike protein; variants.
Conflict of interest statement
Figures
Similar articles
-
Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.Infect Genet Evol. 2022 Jan;97:105164. doi: 10.1016/j.meegid.2021.105164. Epub 2021 Nov 27. Infect Genet Evol. 2022. PMID: 34848355 Free PMC article.
-
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.mBio. 2021 Dec 21;12(6):e0265621. doi: 10.1128/mBio.02656-21. Epub 2021 Dec 7. mBio. 2021. PMID: 34872349 Free PMC article.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.J Med Virol. 2022 Apr;94(4):1300-1314. doi: 10.1002/jmv.27467. Epub 2021 Nov 29. J Med Virol. 2022. PMID: 34811761 Free PMC article. Review.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
Cited by
-
Clinical characteristics and severity markers in hospitalized COVID-19 patients from western Mexico: a comparative analysis of Delta and Omicron variants.Front Public Health. 2024 Aug 30;12:1425372. doi: 10.3389/fpubh.2024.1425372. eCollection 2024. Front Public Health. 2024. PMID: 39281077 Free PMC article.
-
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2.Viruses. 2023 Mar 6;15(3):686. doi: 10.3390/v15030686. Viruses. 2023. PMID: 36992394 Free PMC article.
-
COVID-19 therapy and vaccination: a clinical narrative review.Drugs Context. 2023 Feb 7;12:2022-7-2. doi: 10.7573/dic.2022-7-2. eCollection 2023. Drugs Context. 2023. PMID: 36793450 Free PMC article. Review.
-
Characteristics and Trends of COVID-19 Infection in a Tertiary Hospital in Romania: A Retrospective Study.J Pers Med. 2022 Nov 18;12(11):1928. doi: 10.3390/jpm12111928. J Pers Med. 2022. PMID: 36422104 Free PMC article.
-
Insight into SARS-CoV-2 Omicron variants in Saudi Arabian genomic isolates.Saudi Med J. 2022 Nov;43(11):1276-1279. doi: 10.15537/smj.2022.43.11.20220381. Saudi Med J. 2022. PMID: 36379532 Free PMC article.
References
-
- Kupferschmidt K. Fast-spreading UK virus variant raises alarms. Am Assoc Advance Sci 2021;371:9--10 - PubMed
-
- Wise J. Covid-19: new coronavirus variant is identified in UK. United Kingdom: British Medical Journal Publishing Group, 2020 - PubMed
-
- Lauring AS, Hodcroft EB. Genetic variants of SARS-CoV-2 – what do they mean? JAMA 2021;325:529--31 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous